首页 > 最新文献

Epidemiology最新文献

英文 中文
Generalizability Analyses with a Partially Nested Trial Design: The Necrotizing Enterocolitis Surgery Trial. 部分嵌套试验设计的概括性分析:坏死性小肠结肠炎手术试验。
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2025-06-05 DOI: 10.1097/EDE.0000000000001875
Sarah E Robertson, Matthew A Rysavy, Martin L Blakely, Jon A Steingrimsson, Issa J Dahabreh

We discuss generalizability analyses under a partially nested trial design, where part of the trial is nested within a cohort of trial-eligible individuals, while the rest of the trial is not nested. This design arises, for example, when only some centers participating in a trial are able to collect data on non-randomized individuals, or when data on non-randomized individuals cannot be collected for the full duration of the trial. Our work is motivated by the Necrotizing Enterocolitis Surgery Trial, which compared initial laparotomy versus peritoneal drain for infants with necrotizing enterocolitis or spontaneous intestinal perforation. During the first phase of the study, data were collected from randomized individuals as well as consenting non-randomized individuals; during the second phase of the study, however, data were only collected from randomized individuals, resulting in a partially nested trial design. We propose methods for generalizability analyses with partially nested trial designs. We describe identification conditions and propose estimators for causal estimands in the target population of all trial-eligible individuals, both randomized and non-randomized, in the part of the data where the trial is nested while using trial information spanning both parts. We evaluate the estimators in a simulation study and provide an illustration using the Necrotizing Enterocolitis Surgery Trial study.

我们讨论了部分嵌套试验设计下的概括性分析,其中部分试验嵌套在符合试验条件的个体队列中,而其余试验不嵌套。例如,当只有一些参与试验的中心能够收集非随机个体的数据时,或者当在整个试验期间无法收集非随机个体的数据时,这种设计就会出现。我们的研究是由坏死性小肠结肠炎手术试验推动的,该试验比较了婴儿坏死性小肠结肠炎或自发性肠穿孔的初始剖腹手术与腹膜引流。在研究的第一阶段,从随机个体和同意的非随机个体中收集数据;然而,在研究的第二阶段,数据仅从随机个体中收集,导致部分嵌套试验设计。我们提出了部分嵌套试验设计的概括性分析方法。我们描述了所有符合试验条件的个体(包括随机和非随机)的目标人群的识别条件,并在试验嵌套的数据部分中使用跨越两部分的试验信息,提出了因果估计的估计量。我们在模拟研究中评估了这些估计值,并使用坏死性小肠结肠炎手术试验研究提供了一个例证。
{"title":"Generalizability Analyses with a Partially Nested Trial Design: The Necrotizing Enterocolitis Surgery Trial.","authors":"Sarah E Robertson, Matthew A Rysavy, Martin L Blakely, Jon A Steingrimsson, Issa J Dahabreh","doi":"10.1097/EDE.0000000000001875","DOIUrl":"10.1097/EDE.0000000000001875","url":null,"abstract":"<p><p>We discuss generalizability analyses under a partially nested trial design, where part of the trial is nested within a cohort of trial-eligible individuals, while the rest of the trial is not nested. This design arises, for example, when only some centers participating in a trial are able to collect data on non-randomized individuals, or when data on non-randomized individuals cannot be collected for the full duration of the trial. Our work is motivated by the Necrotizing Enterocolitis Surgery Trial, which compared initial laparotomy versus peritoneal drain for infants with necrotizing enterocolitis or spontaneous intestinal perforation. During the first phase of the study, data were collected from randomized individuals as well as consenting non-randomized individuals; during the second phase of the study, however, data were only collected from randomized individuals, resulting in a partially nested trial design. We propose methods for generalizability analyses with partially nested trial designs. We describe identification conditions and propose estimators for causal estimands in the target population of all trial-eligible individuals, both randomized and non-randomized, in the part of the data where the trial is nested while using trial information spanning both parts. We evaluate the estimators in a simulation study and provide an illustration using the Necrotizing Enterocolitis Surgery Trial study.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"177-186"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144233557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Lactation Information from Electronic Health Records with Survey Data Across Five US Health Systems. 美国五个卫生系统中电子健康记录与调查数据的哺乳信息比较
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2026-01-29 DOI: 10.1097/EDE.0000000000001931
Gregory P Jansen, Elisabeth M Seburg, Gabriela Vazquez-Benitez, Kirsten Ehresmann, Hibo H Mohamed, Lyndsay A Avalos, Sonya Negriff, Amy M Loree, Connor K Howick, Yihe G Daida, Kristin Palmsten

Background: Data on lactation status for research are often collected through surveys. Information on human milk feeding collected at routine healthcare visits and stored in electronic health records (EHR) is an emerging source of data for lactation research. We compared information on milk feeding obtained from structured EHR fields with survey data.

Methods: We included participants from five US healthcare systems in the Managing Our Mood survey. Individuals had a live birth (March 2022-October 2023), depression diagnosis during pregnancy, and ≥1 record of human milk feeding information in their or their infant's EHR. We compared information from EHR data up to ten months after delivery with survey data collected 3-4 months after delivery as the reference. We assessed agreement on lactation status (human milk feeding ever and at survey) using percent agreement, Cohen's kappa, sensitivity, specificity, positive predictive value, and negative predictive value overall and by characteristics.

Results: According to survey data, the prevalence of human milk feeding ever was 93.2% and was 73.0% at the time of survey among 281 eligible individuals. Agreement between data sources for ever and for human milk feeding at the survey was ≥92% with kappas ≥0.77. EHR and survey data agreed on human milk feeding ever for 97.3% (95% confidence interval: 94.6%, 98.7%) and on human milk feeding at the time of the survey for 98.0% (95% confidence interval: 95.1%, 99.2%) of those who reported yes to these practices on the survey. These measurements were lower among individuals with fewer records.

Conclusions: There was substantial agreement on lactation status between EHR and survey data. These findings suggest that lactation information from structured EHR may be used for epidemiologic research.

研究背景:哺乳状况的数据通常是通过调查收集的。在日常保健访问中收集并存储在电子健康记录(EHR)中的母乳喂养信息是哺乳研究的新兴数据来源。我们比较了从结构化电子病历领域获得的母乳喂养信息与调查数据。方法:我们在管理我们的情绪调查中纳入了来自美国五个医疗保健系统的参与者。个体有活产(2022年3月至2023年10月),怀孕期间有抑郁症诊断,在其或其婴儿的电子病历中有至少1项母乳喂养信息记录。我们将分娩后10个月的电子病历数据与分娩后3-4个月的调查数据作为参考进行比较。我们使用一致性百分比、Cohen’s kappa、敏感性、特异性、PPV和NPV总体和按特征评估泌乳状态(母乳喂养时和调查时)的一致性。结果:调查数据显示,281名符合条件的人群中,曾经母乳喂养率为93.2%,调查时母乳喂养率为73.0%。所有数据源与调查时母乳喂养数据的一致性≥92%,kappas≥0.77。电子病历和调查数据一致的是,97.3%(95%置信区间:94.6%,98.7%)的人曾经母乳喂养,98.0%(95%置信区间:95.1%,99.2%)的人在调查时母乳喂养。这些测量值在记录较少的个体中较低。结论:电子病历与调查数据在泌乳状况上有很大的一致性。这些发现提示结构化电子病历中的泌乳信息可用于流行病学研究。
{"title":"Comparison of Lactation Information from Electronic Health Records with Survey Data Across Five US Health Systems.","authors":"Gregory P Jansen, Elisabeth M Seburg, Gabriela Vazquez-Benitez, Kirsten Ehresmann, Hibo H Mohamed, Lyndsay A Avalos, Sonya Negriff, Amy M Loree, Connor K Howick, Yihe G Daida, Kristin Palmsten","doi":"10.1097/EDE.0000000000001931","DOIUrl":"10.1097/EDE.0000000000001931","url":null,"abstract":"<p><strong>Background: </strong>Data on lactation status for research are often collected through surveys. Information on human milk feeding collected at routine healthcare visits and stored in electronic health records (EHR) is an emerging source of data for lactation research. We compared information on milk feeding obtained from structured EHR fields with survey data.</p><p><strong>Methods: </strong>We included participants from five US healthcare systems in the Managing Our Mood survey. Individuals had a live birth (March 2022-October 2023), depression diagnosis during pregnancy, and ≥1 record of human milk feeding information in their or their infant's EHR. We compared information from EHR data up to ten months after delivery with survey data collected 3-4 months after delivery as the reference. We assessed agreement on lactation status (human milk feeding ever and at survey) using percent agreement, Cohen's kappa, sensitivity, specificity, positive predictive value, and negative predictive value overall and by characteristics.</p><p><strong>Results: </strong>According to survey data, the prevalence of human milk feeding ever was 93.2% and was 73.0% at the time of survey among 281 eligible individuals. Agreement between data sources for ever and for human milk feeding at the survey was ≥92% with kappas ≥0.77. EHR and survey data agreed on human milk feeding ever for 97.3% (95% confidence interval: 94.6%, 98.7%) and on human milk feeding at the time of the survey for 98.0% (95% confidence interval: 95.1%, 99.2%) of those who reported yes to these practices on the survey. These measurements were lower among individuals with fewer records.</p><p><strong>Conclusions: </strong>There was substantial agreement on lactation status between EHR and survey data. These findings suggest that lactation information from structured EHR may be used for epidemiologic research.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"198-206"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145700019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of School Reopenings on Children's Mental Health During COVID-19: Quasi-experimental Evidence from California. COVID-19期间学校复课对儿童心理健康的影响:来自加利福尼亚州的准实验证据
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2026-01-29 DOI: 10.1097/EDE.0000000000001930
Pelin Ozluk, Jeff Romine, Gosia Sylwestrzak, Rita Hamad

Background: School closures during the coronavirus disease 2019 pandemic disrupted children's education, socialization, and access to mental health resources, raising concerns about long-term effects on childrens' mental health. The objective was to evaluate the impacts of pandemic-era school reopenings on children's mental health and healthcare expenditures. Variation in the timing of school reopenings created a unique quasi-experiment.

Methods: We used difference-in-differences analysis to examine how staggered implementation of school reopenings affected diagnoses with depression, anxiety, and attention-deficit/hyperactivity disorder, and related healthcare spending among school-aged children during March 2020-June 2021 across 24 California counties. Data were drawn from medical claims from the second largest private health insurer in the state (N = 185,735).

Results: School reopening was associated with a 1.2%-point drop in monthly prevalence of mental health diagnoses [95% confidence interval (CI) = -1.59, -0.74], and a 10.6% (95% CI = -13.4%, -7.8%) drop in related healthcare spending. The mental health conditions that saw the largest differential between in-person and remote school districts were anxiety and depression. Effects were strongest among girls.

Conclusions: In-person learning is an important component of children's mental health. These results are informative for future policymaking during public health crises, to balance infection risk with the need for socialization and other critical resources that schools provide to children.

背景:2019冠状病毒病大流行期间学校关闭扰乱了儿童的教育、社交和获得精神卫生资源的机会,引发了对儿童心理健康长期影响的担忧。目的是评估大流行时期学校复课对儿童心理健康和保健支出的影响。学校重新开放时间的变化创造了一个独特的准实验。方法:我们使用差异中差异分析来检查交错实施学校重新开放如何影响2020年3月至2021年6月期间加州24个县的学龄儿童的抑郁、焦虑和注意力缺陷/多动障碍的诊断,以及相关的医疗保健支出。数据来自该州第二大私人健康保险公司的医疗索赔(N=185,735)。结果:学校重新开学与每月心理健康诊断患病率下降1.2% (95%CI: -1.59, -0.74)以及相关医疗保健支出下降10.6% (95%CI: -13.4%, -7.8%)相关。在心理健康状况上,亲身学区和偏远学区之间最大的差异是焦虑和抑郁。这种影响在女孩中最为明显。结论:亲临学习是儿童心理健康的重要组成部分。这些结果为未来在公共卫生危机期间制定政策提供了信息,以平衡感染风险与学校向儿童提供的社会化和其他关键资源的需求。
{"title":"Effect of School Reopenings on Children's Mental Health During COVID-19: Quasi-experimental Evidence from California.","authors":"Pelin Ozluk, Jeff Romine, Gosia Sylwestrzak, Rita Hamad","doi":"10.1097/EDE.0000000000001930","DOIUrl":"10.1097/EDE.0000000000001930","url":null,"abstract":"<p><strong>Background: </strong>School closures during the coronavirus disease 2019 pandemic disrupted children's education, socialization, and access to mental health resources, raising concerns about long-term effects on childrens' mental health. The objective was to evaluate the impacts of pandemic-era school reopenings on children's mental health and healthcare expenditures. Variation in the timing of school reopenings created a unique quasi-experiment.</p><p><strong>Methods: </strong>We used difference-in-differences analysis to examine how staggered implementation of school reopenings affected diagnoses with depression, anxiety, and attention-deficit/hyperactivity disorder, and related healthcare spending among school-aged children during March 2020-June 2021 across 24 California counties. Data were drawn from medical claims from the second largest private health insurer in the state (N = 185,735).</p><p><strong>Results: </strong>School reopening was associated with a 1.2%-point drop in monthly prevalence of mental health diagnoses [95% confidence interval (CI) = -1.59, -0.74], and a 10.6% (95% CI = -13.4%, -7.8%) drop in related healthcare spending. The mental health conditions that saw the largest differential between in-person and remote school districts were anxiety and depression. Effects were strongest among girls.</p><p><strong>Conclusions: </strong>In-person learning is an important component of children's mental health. These results are informative for future policymaking during public health crises, to balance infection risk with the need for socialization and other critical resources that schools provide to children.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"257-267"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12824883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neighborhood-level Measures of Structural Racism and Severe Maternal Morbidity Among Black Mothers in California. 加州黑人母亲中结构性种族主义和严重产妇发病率的社区水平测量。
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2026-01-29 DOI: 10.1097/EDE.0000000000001941
Elleni M Hailu, Corinne A Riddell, Mahader Tamene, Suzan L Carmichael, Mahasin S Mujahid

Background: Drivers of persistent racial-ethnic inequities in severe maternal morbidity are poorly understood. This study examined how neighborhood-level structural racism measures shape risk of severe maternal morbidity among Black mothers.

Methods: Data are from live hospital births in California between 1997 and 2019 at ≥20 weeks' gestation (N = 555,511). We leveraged information from the U.S. Census Bureau and the American Community Survey to determine neighborhood (census tract) measures of structural racism across six domains (homeownership, unemployment, poverty, educational attainment, racialized economic deprivation, and racial residential segregation). We used (1) an additive composite index (quartile 1 [low]-quartile 4 [high]) and (2) latent class analysis to characterize four structural racism typologies. We examined associations across both measurement approaches using mixed-effects logistic regression models with neighborhood random intercepts, adjusting for maternal age, education, and hospital payer/insurance information.

Results: Black mothers living in neighborhoods scoring high (quartile 4) on the additive composite index had 13% higher risk of severe maternal morbidity than those in neighborhoods scoring low (quartile 1) (95% confidence interval = 1.04, 1.24). Models evaluating latent class typologies also revealed that Black mothers living in neighborhoods characterized by consistently high racial inequity in unemployment, racialized economic deprivation, and racial residential segregation across the study period had a 12% higher risk of severe maternal morbidity compared with those in neighborhoods consistently scoring low in the domains examined (95% confidence interval = 1.03, 1.23).

Conclusions: Our findings support the hypothesis that neighborhood-level measures of structural racism influence the risk of severe maternal morbidity among Black mothers.

背景:严重孕产妇发病率中持续存在的种族-民族不平等的驱动因素尚不清楚。本研究考察了社区水平的结构性种族主义如何影响黑人母亲严重产妇发病率的风险。方法:数据来自加利福尼亚州1997-2019年妊娠≥20周的医院活产婴儿(N=555,511)。我们利用来自美国人口普查局和美国社区调查的信息,确定了六个领域(住房所有权、失业、贫困、教育程度、种族化经济剥夺和种族居住隔离)的社区(人口普查区)结构性种族主义措施。我们使用了1)加性复合指数(四分位数1(低)-四分位数4(高))和2)潜在类别分析来表征四种结构性种族主义类型。我们使用混合效应逻辑回归模型对两种测量方法之间的关联进行了检验,该模型具有邻域随机截距,调整了产妇年龄、教育程度和医院付款人信息。结果:居住在加性综合指数得分高的社区(四分位数4)的黑人母亲比居住在得分低的社区(四分位数1)的黑人母亲严重孕产妇发病的风险高13%(95%置信区间(CI): 1.04-1.24)。评估潜在阶级类型的模型还显示,在整个研究期间,生活在失业率、种族化经济剥夺和种族居住隔离方面持续高度种族不平等的社区的黑人母亲,与那些在研究领域中持续得分较低的社区的黑人母亲相比,严重孕产妇发病率的风险高出12% (95% CI: 1.03-1.23)。结论:我们的研究结果支持这样的假设,即社区水平的结构性种族主义测量影响黑人母亲严重产妇发病率的风险。
{"title":"Neighborhood-level Measures of Structural Racism and Severe Maternal Morbidity Among Black Mothers in California.","authors":"Elleni M Hailu, Corinne A Riddell, Mahader Tamene, Suzan L Carmichael, Mahasin S Mujahid","doi":"10.1097/EDE.0000000000001941","DOIUrl":"10.1097/EDE.0000000000001941","url":null,"abstract":"<p><strong>Background: </strong>Drivers of persistent racial-ethnic inequities in severe maternal morbidity are poorly understood. This study examined how neighborhood-level structural racism measures shape risk of severe maternal morbidity among Black mothers.</p><p><strong>Methods: </strong>Data are from live hospital births in California between 1997 and 2019 at ≥20 weeks' gestation (N = 555,511). We leveraged information from the U.S. Census Bureau and the American Community Survey to determine neighborhood (census tract) measures of structural racism across six domains (homeownership, unemployment, poverty, educational attainment, racialized economic deprivation, and racial residential segregation). We used (1) an additive composite index (quartile 1 [low]-quartile 4 [high]) and (2) latent class analysis to characterize four structural racism typologies. We examined associations across both measurement approaches using mixed-effects logistic regression models with neighborhood random intercepts, adjusting for maternal age, education, and hospital payer/insurance information.</p><p><strong>Results: </strong>Black mothers living in neighborhoods scoring high (quartile 4) on the additive composite index had 13% higher risk of severe maternal morbidity than those in neighborhoods scoring low (quartile 1) (95% confidence interval = 1.04, 1.24). Models evaluating latent class typologies also revealed that Black mothers living in neighborhoods characterized by consistently high racial inequity in unemployment, racialized economic deprivation, and racial residential segregation across the study period had a 12% higher risk of severe maternal morbidity compared with those in neighborhoods consistently scoring low in the domains examined (95% confidence interval = 1.03, 1.23).</p><p><strong>Conclusions: </strong>Our findings support the hypothesis that neighborhood-level measures of structural racism influence the risk of severe maternal morbidity among Black mothers.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"247-256"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longer-term Survival of UK People with Bleeding Disorders Infected by Human Immunodeficiency Virus and/or Hepatitis C Virus Through Contaminated Blood Transfusions. 通过受污染的输血感染人类免疫缺陷病毒和/或丙型肝炎病毒的英国出血性疾病患者的长期生存率。
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2026-01-29 DOI: 10.1097/EDE.0000000000001935
Matthew Gittins, Ben Palmer, Hua Xiang, Pratima Chowdary, Peter Collins, Sheila M Bird

Background: Between 1970 and 1991, when viral inhibition reduced the risk, people with a bleeding disorder in the United Kingdom had their missing clotting factors replaced with plasma products derived from donated plasma at risk of infection. We analyzed longer-term survival of people with bleeding disorders exposed to plasma products.

Methods: The National Haemophilia Database documents people with bleeding disorders registered, treated before, and alive on 1 January 1992. We estimated all-cause mortality proportional hazard ratios for exposure groups (Human immunodeficiency virus (HIV)/Hepatitis C virus (HCV) coinfected, HCV-diagnosed, and HCV-status unknown) versus HCV antibody negative, within distinct epochs: 1992-1999; 2000-2009; 2010-2019. We estimated years of life lost by epoch and exposure group versus UK general population lifetables or via parametric survival models compared with people with bleeding disorders negative or unknown for HCV antibodies. Models were adjusted for sex, age band at 1 January 1992, bleeding disorder, and severity.

Results: Of 6282 people with bleeding disorders who met inclusion criteria, 15% were HIV/HCV coinfected, 32% HCV antibody positive, and 28% HCV antibody negative. Compared with HCV-negative, those HIV/HCV coinfected had an all-cause mortality hazard ratio of 4.2 (95% confidence interval: 2.9, 6.0) and HCV+ of 2.2 (1.7, 2.8) in 2010 to 2019. Years of life lost for 2014 to 2019 were 740 (95% confidence interval: 440, 1030) for HCV+ persons and 270 (130, 400) for HIV/HCV coinfected persons, compared with HCV unknown or negative persons.

Conclusions: People with bleeding disorders in the United Kingdom infected before, but alive at, 1 January 1992, were still at increased risk of death 3 decades postimplementation of HCV screening of blood supplies.

背景:在1970-1991年期间,当病毒抑制降低风险时,英国出血性疾病患者将其缺失的凝血因子替换为来自有感染风险的捐献血浆的血浆产品。我们分析了暴露于血浆产品的出血性疾病患者的长期生存率。方法:国家血友病数据库记录了1992年1月1日登记、治疗和存活的出血性疾病患者。在不同时期,我们估计了暴露组(人类免疫缺陷病毒(HIV)/丙型肝炎病毒(HCV)共感染、HCV诊断和HCV状态未知)与HCV抗体阴性的全因死亡率比例风险比(HR): 1992-1999;2000 - 2009;2010 - 2019。我们通过时代和暴露组与英国一般人群生命表或参数生存模型比较出血性疾病患者的HCV抗体阴性或未知的寿命损失年数(YLL)。模型根据性别、1992年1月1日的年龄、出血性疾病和严重程度进行了调整。结果:6282例符合纳入标准的出血性疾病患者中,15%为HIV/HCV合并感染,32%为HCV抗体阳性,28%为HCV抗体阴性。2010- 2019年,与HCV阴性患者相比,HIV/HCV合并感染者的全因死亡率HR为4.2 (95% CI 2.9,6.0), HCV阳性患者的全因死亡率HR为2.2(95% CI 1.7,2.8)。与HCV未知或阴性者相比,2014-19年HCV阳性者的YLL为740(95% CI为440,1030),HIV/HCV合并感染者的YLL为270(130,400)。结论:在英国,1992年1月1日之前感染但存活的出血性疾病患者,在实施HCV血液供应筛查30年后,死亡风险仍在增加。
{"title":"Longer-term Survival of UK People with Bleeding Disorders Infected by Human Immunodeficiency Virus and/or Hepatitis C Virus Through Contaminated Blood Transfusions.","authors":"Matthew Gittins, Ben Palmer, Hua Xiang, Pratima Chowdary, Peter Collins, Sheila M Bird","doi":"10.1097/EDE.0000000000001935","DOIUrl":"10.1097/EDE.0000000000001935","url":null,"abstract":"<p><strong>Background: </strong>Between 1970 and 1991, when viral inhibition reduced the risk, people with a bleeding disorder in the United Kingdom had their missing clotting factors replaced with plasma products derived from donated plasma at risk of infection. We analyzed longer-term survival of people with bleeding disorders exposed to plasma products.</p><p><strong>Methods: </strong>The National Haemophilia Database documents people with bleeding disorders registered, treated before, and alive on 1 January 1992. We estimated all-cause mortality proportional hazard ratios for exposure groups (Human immunodeficiency virus (HIV)/Hepatitis C virus (HCV) coinfected, HCV-diagnosed, and HCV-status unknown) versus HCV antibody negative, within distinct epochs: 1992-1999; 2000-2009; 2010-2019. We estimated years of life lost by epoch and exposure group versus UK general population lifetables or via parametric survival models compared with people with bleeding disorders negative or unknown for HCV antibodies. Models were adjusted for sex, age band at 1 January 1992, bleeding disorder, and severity.</p><p><strong>Results: </strong>Of 6282 people with bleeding disorders who met inclusion criteria, 15% were HIV/HCV coinfected, 32% HCV antibody positive, and 28% HCV antibody negative. Compared with HCV-negative, those HIV/HCV coinfected had an all-cause mortality hazard ratio of 4.2 (95% confidence interval: 2.9, 6.0) and HCV+ of 2.2 (1.7, 2.8) in 2010 to 2019. Years of life lost for 2014 to 2019 were 740 (95% confidence interval: 440, 1030) for HCV+ persons and 270 (130, 400) for HIV/HCV coinfected persons, compared with HCV unknown or negative persons.</p><p><strong>Conclusions: </strong>People with bleeding disorders in the United Kingdom infected before, but alive at, 1 January 1992, were still at increased risk of death 3 decades postimplementation of HCV screening of blood supplies.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"237-246"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Ideal Trial: Defining Causal Estimands that Balance Relevance and Feasibility in Target Trial Emulations and Actual Randomized Trials. 理想的试验:在目标试验模拟和实际随机试验中,定义平衡相关性和可行性的因果估计。
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2026-01-02 DOI: 10.1097/EDE.0000000000001933
Margarita Moreno-Betancur, Rushani Wijesuriya, John B Carlin

Causal inference is the goal of randomized trials and many observational studies. The first step in a formal causal inference framework is to define the causal estimand, and in both types of study this can be done mathematically or, equivalently, by specifying an ideal trial: a hypothetical perfect randomized experiment (with representative sample, perfect adherence, etc). The target trial framework is increasingly used for causal inference in observational studies, but clarity is lacking in how a target trial should be specified and how it relates to an ideal trial. Here, we review the mathematical and ideal trial approaches to defining a causal estimand, highlighting their equivalence and the need to balance practical relevance and feasibility of estimation regardless of approach. We then consider the question of how a target trial should be specified, outlining the challenges of a recommended approach, commonly seen in applications, that puts the focus heavily on the feasibility of estimation: to specify the target trial such that it is closely aligned with the observational data (e.g., uses the same eligibility criteria). We argue that with this "aligned" approach, biases may remain relative to the estimand of ultimate practical interest, defined by the ideal trial, that mirror the often-overlooked biases of actual trials. We conclude that consideration of the ideal trial and of how the target trial and its emulation or the actual trial differ from it is necessary to identify and manage all bias sources in both settings. An example from respiratory epidemiology is used for illustration.

因果推理是随机试验和许多观察性研究的目标。正式因果推理框架的第一步是定义因果估计,在这两种类型的研究中,都可以用数学方法来完成,或者同样地,通过指定一个理想的试验来完成:一个假设的完美随机实验(具有代表性样本,完美依从性等)。在观察性研究中,目标试验框架越来越多地用于因果推断,但在如何指定目标试验以及它与理想试验的关系方面缺乏清晰度。在这里,我们回顾了定义因果估计的数学和理想试验方法,强调了它们的等价性,以及无论采用哪种方法,都需要平衡估计的实际相关性和可行性。然后,我们考虑如何指定目标试验的问题,概述了在应用程序中常见的推荐方法的挑战,该方法将重点放在估计的可行性上:指定目标试验,使其与观察数据密切一致(例如,使用相同的资格标准)。我们认为,通过这种“一致”的方法,偏差可能仍然相对于最终实际利益的估计,由理想试验定义,反映了实际试验中经常被忽视的偏差。我们的结论是,考虑理想试验以及目标试验及其模拟或实际试验与理想试验的不同之处,有必要识别和管理两种情况下的所有偏倚源。本文以呼吸道流行病学为例进行说明。
{"title":"The Ideal Trial: Defining Causal Estimands that Balance Relevance and Feasibility in Target Trial Emulations and Actual Randomized Trials.","authors":"Margarita Moreno-Betancur, Rushani Wijesuriya, John B Carlin","doi":"10.1097/EDE.0000000000001933","DOIUrl":"10.1097/EDE.0000000000001933","url":null,"abstract":"<p><p>Causal inference is the goal of randomized trials and many observational studies. The first step in a formal causal inference framework is to define the causal estimand, and in both types of study this can be done mathematically or, equivalently, by specifying an ideal trial: a hypothetical perfect randomized experiment (with representative sample, perfect adherence, etc). The target trial framework is increasingly used for causal inference in observational studies, but clarity is lacking in how a target trial should be specified and how it relates to an ideal trial. Here, we review the mathematical and ideal trial approaches to defining a causal estimand, highlighting their equivalence and the need to balance practical relevance and feasibility of estimation regardless of approach. We then consider the question of how a target trial should be specified, outlining the challenges of a recommended approach, commonly seen in applications, that puts the focus heavily on the feasibility of estimation: to specify the target trial such that it is closely aligned with the observational data (e.g., uses the same eligibility criteria). We argue that with this \"aligned\" approach, biases may remain relative to the estimand of ultimate practical interest, defined by the ideal trial, that mirror the often-overlooked biases of actual trials. We conclude that consideration of the ideal trial and of how the target trial and its emulation or the actual trial differ from it is necessary to identify and manage all bias sources in both settings. An example from respiratory epidemiology is used for illustration.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"153-162"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12851543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145905963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Pooling Method for Nonlinear Cohort Analysis and Meta-analysis Estimates: Predicting Health Outcomes from Dietary Changes. 非线性队列分析和荟萃分析估计的新池化方法:预测饮食变化的健康结果。
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2026-01-05 DOI: 10.1097/EDE.0000000000001932
Tommi Härkänen, Heli Tapanainen, Laura Sares-Jäske, Satu Männistö, Niina E Kaartinen, Laura Paalanen

Background: Projections for major health outcomes are crucial for decision-making to enable early interventions. Pooling results from meta-analyses with estimates based on individual participant data can reduce uncertainty and improve generalizability. However, current methods for meta-meta-analyses of nonlinear functions have remained underdeveloped.

Methods: We proposed a novel meta-analysis method to pool pointwise nonlinear function literature estimates with parameter estimates, applied here to the association of dietary change scenarios with mortality and ischemic heart disease (IHD) based on Finnish individual participant data. We linked individual-level demographic and risk factor data from the Health 2000, FINRISK 2007, FINRISK 2012, and FinHealth 2017 surveys (n = 20,784) with follow-up data on outcomes obtained from national health registers. We applied a Poisson multistate model and microsimulation to project state probabilities.

Results: Pooling reduced uncertainty in the hazard ratio estimates and in the health projections. We estimated that a two-thirds reduction in red and processed meat consumption would decrease the prevalence of IHD by 2 (95% prediction intervals [PI] 1, 4) percentage points (%pt) in the 2017 cohort and deaths by 2%pt (95% PI 1, 4) by 2050. We estimated that a 100% increase in whole grain consumption would reduce IHD by 2%pt (95% PI 0, 3) and deaths by 2%pt (95% PI 0, 3).

Conclusions: Our flexible meta-analysis method allowed the pooling of nonlinear estimates reported in the literature without detailed technical information. Our estimates support the hypothesis that more plant-based diets reduce mortality and IHD prevalence. The most beneficial scenarios included reductions in red and processed meat and increments in whole grain consumption.

背景:对主要健康结果的预测对于能够进行早期干预的决策至关重要。汇总meta分析的结果和基于个体参与者数据的估计可以减少不确定性,提高普遍性。然而,目前的非线性函数元-元分析方法仍然不发达。方法:我们提出了一种新的荟萃分析方法,将点非线性函数文献估计与参数估计结合起来,应用于基于芬兰个体参与者数据的饮食改变情景与死亡率和缺血性心脏病的关联。我们将来自Health 2000、FINRISK 2007、FINRISK 2012和FinHealth 2017调查(n=20,784)的个人层面人口统计学和风险因素数据与来自国家健康登记册的随访数据联系起来。我们应用泊松多态模型和微观模拟来预测状态概率。结果:合并减少了风险比估计和健康预测的不确定性。我们估计,到2050年,红肉和加工肉类消费量减少三分之二将使2017年队列中IHD患病率降低2个百分点(95%预测区间PI 1,4),死亡率降低2% (95% PI 1,4)。我们估计,全谷物消费量增加100%将使IHD降低2% (95% PI 0,3),死亡率降低2% (95% PI 0,3)。结论:我们灵活的荟萃分析方法可以汇集文献中报道的非线性估计,而不需要详细的技术信息。我们的估计支持更多植物性饮食降低死亡率和IHD患病率的假设。最有益的方案包括减少红肉和加工肉,增加全谷物消费。
{"title":"Novel Pooling Method for Nonlinear Cohort Analysis and Meta-analysis Estimates: Predicting Health Outcomes from Dietary Changes.","authors":"Tommi Härkänen, Heli Tapanainen, Laura Sares-Jäske, Satu Männistö, Niina E Kaartinen, Laura Paalanen","doi":"10.1097/EDE.0000000000001932","DOIUrl":"10.1097/EDE.0000000000001932","url":null,"abstract":"<p><strong>Background: </strong>Projections for major health outcomes are crucial for decision-making to enable early interventions. Pooling results from meta-analyses with estimates based on individual participant data can reduce uncertainty and improve generalizability. However, current methods for meta-meta-analyses of nonlinear functions have remained underdeveloped.</p><p><strong>Methods: </strong>We proposed a novel meta-analysis method to pool pointwise nonlinear function literature estimates with parameter estimates, applied here to the association of dietary change scenarios with mortality and ischemic heart disease (IHD) based on Finnish individual participant data. We linked individual-level demographic and risk factor data from the Health 2000, FINRISK 2007, FINRISK 2012, and FinHealth 2017 surveys (n = 20,784) with follow-up data on outcomes obtained from national health registers. We applied a Poisson multistate model and microsimulation to project state probabilities.</p><p><strong>Results: </strong>Pooling reduced uncertainty in the hazard ratio estimates and in the health projections. We estimated that a two-thirds reduction in red and processed meat consumption would decrease the prevalence of IHD by 2 (95% prediction intervals [PI] 1, 4) percentage points (%pt) in the 2017 cohort and deaths by 2%pt (95% PI 1, 4) by 2050. We estimated that a 100% increase in whole grain consumption would reduce IHD by 2%pt (95% PI 0, 3) and deaths by 2%pt (95% PI 0, 3).</p><p><strong>Conclusions: </strong>Our flexible meta-analysis method allowed the pooling of nonlinear estimates reported in the literature without detailed technical information. Our estimates support the hypothesis that more plant-based diets reduce mortality and IHD prevalence. The most beneficial scenarios included reductions in red and processed meat and increments in whole grain consumption.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"187-197"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12851546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145932798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Area-level Patient Density and Physician Prescribing Preference Instruments for the Effect of Antidiabetics on Adverse Cardiovascular Events Among Medicare Beneficiaries. 比较区域水平患者密度和医生处方偏好工具对医疗保险受益人中抗糖尿病药物对不良心血管事件的影响。
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2026-01-29 DOI: 10.1097/EDE.0000000000001938
Jack Cordes, Robert J Glynn, Alexander M Walker, Sebastian S Schneeweiss

Background: Randomized trials of major adverse cardiovascular events found no effect of dipeptidyl-peptidase-4 inhibitors (DPP-4i) medications compared with second-generation sulfonylureas, while nonrandomized studies estimated a benefit of DPP-4i. Socioeconomic residual confounding was thought to be implicated. We compared area-level prescribing density and physician prescribing preference as candidate instrumental variables for the effect of DPP-4i medications on major adverse cardiovascular events.

Methods: Using Medicare claims data, we built two cohorts emulating randomized trials of sitagliptin or saxagliptin starters, each compared with sulfonylurea starters. The proportion of DPP-4i prescribing in a ZIP Code tabulation area defined the area-level prescribing density instrumental variable at various cutoffs (0% vs. 100% to <50% vs. ≥50%). Patients' physician prescribing history using the same proportion cutoffs was the physician prescribing preference candidate instrumental variable. An instantaneous physician preference instrumental variable used a physician's most recent prescription. We adjusted two-stage instrumental variable regression models for propensity score quintiles.

Results: Unadjusted analyses for sitagliptin and saxagliptin, each compared with sulfonylurea, estimated a reduced risk of major adverse cardiovascular events [sitagliptin hazard ratio (HR) = 0.86; 95% confidence interval = 0.83, 0.88]; saxagliptin (HR = 0.68; 0.64, 0.73). All instrumental variables were strong and reduced covariate imbalance. Analyses of area-level prescribing density found no meaningful difference for sitagliptin (0% vs. 100% HR = 1.1; 0.79, 1.6). Analyses of physician prescribing preference estimated reduced risk for sitagliptin (<50% vs. ≥50% HR = 0.69; 0.48, 0.98). Instantaneous physician prescribing preference analyses showed little to no difference for sitagliptin (HR = 0.86; 0.60, 1.1) and saxagliptin (HR = 0.98; 0.56, 1.7).

Conclusions: Candidate instrumental variables focusing on short-term prescribing preference hold promise over area-based variables but remain inefficient.

背景:主要不良心血管事件的随机试验(RCT)发现,与第二代磺脲类药物相比,二肽基肽酶-4抑制剂(DPP-4i)药物没有影响,而非随机研究估计DPP-4i有益。社会经济残留混淆被认为与此有关。我们比较了区域水平的处方密度和医生处方偏好,作为DPP-4i药物对主要不良心血管事件影响的候选工具变量。方法:利用医疗保险索赔数据,我们建立了两个队列,模拟西格列汀或沙格列汀起始剂的随机对照试验,每个队列与磺脲类起始剂进行比较。邮政编码制表区域的DPP-4i处方比例定义了不同截止点的区域级处方密度工具变量(0% vs. 100%)。结果:未经调整的西格列汀和沙格列汀分析,与磺脲类相比,估计主要不良心血管事件的风险降低(西格列汀风险比(HR)=0.86;95%置信区间0.83 ~ 0.88);saxagliptin HR = 0.68;0.64 ~ 0.73)。所有工具变量都很强,协变量不平衡减少。区域水平处方密度分析发现西格列汀无显著差异(0% vs 100% HR=1.1; 0.79 to 1.6)。医生处方偏好分析估计西格列汀降低风险(结论:关注短期处方偏好的候选工具变量比基于区域的变量更有希望,但仍然效率低下。
{"title":"Comparing Area-level Patient Density and Physician Prescribing Preference Instruments for the Effect of Antidiabetics on Adverse Cardiovascular Events Among Medicare Beneficiaries.","authors":"Jack Cordes, Robert J Glynn, Alexander M Walker, Sebastian S Schneeweiss","doi":"10.1097/EDE.0000000000001938","DOIUrl":"10.1097/EDE.0000000000001938","url":null,"abstract":"<p><strong>Background: </strong>Randomized trials of major adverse cardiovascular events found no effect of dipeptidyl-peptidase-4 inhibitors (DPP-4i) medications compared with second-generation sulfonylureas, while nonrandomized studies estimated a benefit of DPP-4i. Socioeconomic residual confounding was thought to be implicated. We compared area-level prescribing density and physician prescribing preference as candidate instrumental variables for the effect of DPP-4i medications on major adverse cardiovascular events.</p><p><strong>Methods: </strong>Using Medicare claims data, we built two cohorts emulating randomized trials of sitagliptin or saxagliptin starters, each compared with sulfonylurea starters. The proportion of DPP-4i prescribing in a ZIP Code tabulation area defined the area-level prescribing density instrumental variable at various cutoffs (0% vs. 100% to <50% vs. ≥50%). Patients' physician prescribing history using the same proportion cutoffs was the physician prescribing preference candidate instrumental variable. An instantaneous physician preference instrumental variable used a physician's most recent prescription. We adjusted two-stage instrumental variable regression models for propensity score quintiles.</p><p><strong>Results: </strong>Unadjusted analyses for sitagliptin and saxagliptin, each compared with sulfonylurea, estimated a reduced risk of major adverse cardiovascular events [sitagliptin hazard ratio (HR) = 0.86; 95% confidence interval = 0.83, 0.88]; saxagliptin (HR = 0.68; 0.64, 0.73). All instrumental variables were strong and reduced covariate imbalance. Analyses of area-level prescribing density found no meaningful difference for sitagliptin (0% vs. 100% HR = 1.1; 0.79, 1.6). Analyses of physician prescribing preference estimated reduced risk for sitagliptin (<50% vs. ≥50% HR = 0.69; 0.48, 0.98). Instantaneous physician prescribing preference analyses showed little to no difference for sitagliptin (HR = 0.86; 0.60, 1.1) and saxagliptin (HR = 0.98; 0.56, 1.7).</p><p><strong>Conclusions: </strong>Candidate instrumental variables focusing on short-term prescribing preference hold promise over area-based variables but remain inefficient.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"207-219"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145761559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Test-negative Designs with Various Reasons for Testing: Statistical Bias and Solution. 测试阴性设计,有各种测试原因:统计偏差和解决方案。
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2025-12-29 DOI: 10.1097/EDE.0000000000001940
Mengxin Yu, Tom Hongyi Liu, Kendrick Qijun Li, Nicholas Jewell, Eric Tchetgen Tchetgen, Dylan Small, Xu Shi, Bingkai Wang

Test-negative designs (TNDs) are widely used for postmarket evaluation of vaccine effectiveness (VE), particularly in cases when randomized trials are not feasible. Unlike classical TNDs, which only include healthcare seekers with symptoms, recent TNDs have involved individuals with various reasons for testing, especially in an outbreak setting. While including these data can increase sample size and hence improve precision, concerns have been raised about whether they introduce bias into the current framework of TNDs, thereby demanding a formal statistical examination of this modified design. In this article, using statistical derivations, causal graphs, and numerical demonstrations, we show that the standard odds ratio estimator may be biased if various reasons for testing are not taken into account. To eliminate this bias, we identify three categories of reasons for testing, namely symptoms, mandatory screening, and case contact tracing, and characterize associated statistical properties and estimands. Based on our characterization, we show how to consistently estimate each estimand via stratification. Furthermore, we describe when these estimands correspond to the same VE parameter and, when appropriate, propose a stratified estimator that can incorporate multiple reasons for testing and improve precision. We demonstrate the performance of our proposed method through simulation studies and a real-data analysis.

试验阴性设计广泛用于疫苗上市后有效性评价,特别是在无法进行随机试验的情况下。与传统的阴性检测设计不同,阴性检测设计只包括有症状的求医者,而最近的阴性检测设计涉及有各种原因需要检测的个体,特别是在疫情背景下。虽然纳入这些数据可以增加样本量,从而提高精度,但人们担心它们是否会在目前的阴性试验设计框架中引入偏差,因此需要对这种修改后的设计进行正式的统计检查。在本文中,使用统计推导、因果图和数值演示,我们表明,如果不考虑检验的各种原因,标准比值比估计器可能会有偏差。为了消除这种偏差,我们确定了检测的三类原因,即症状、强制性筛查和病例接触者追踪,并描述了相关的统计特性和估计。根据我们的特征,我们展示了如何通过分层一致地估计每个估计。此外,我们描述了这些估计值何时对应于相同的疫苗有效性参数,并在适当的情况下提出了一个分层估计值,该估计值可以包含多个测试原因并提高精度。我们通过仿真研究和实际数据分析证明了我们提出的方法的性能。
{"title":"Test-negative Designs with Various Reasons for Testing: Statistical Bias and Solution.","authors":"Mengxin Yu, Tom Hongyi Liu, Kendrick Qijun Li, Nicholas Jewell, Eric Tchetgen Tchetgen, Dylan Small, Xu Shi, Bingkai Wang","doi":"10.1097/EDE.0000000000001940","DOIUrl":"10.1097/EDE.0000000000001940","url":null,"abstract":"<p><p>Test-negative designs (TNDs) are widely used for postmarket evaluation of vaccine effectiveness (VE), particularly in cases when randomized trials are not feasible. Unlike classical TNDs, which only include healthcare seekers with symptoms, recent TNDs have involved individuals with various reasons for testing, especially in an outbreak setting. While including these data can increase sample size and hence improve precision, concerns have been raised about whether they introduce bias into the current framework of TNDs, thereby demanding a formal statistical examination of this modified design. In this article, using statistical derivations, causal graphs, and numerical demonstrations, we show that the standard odds ratio estimator may be biased if various reasons for testing are not taken into account. To eliminate this bias, we identify three categories of reasons for testing, namely symptoms, mandatory screening, and case contact tracing, and characterize associated statistical properties and estimands. Based on our characterization, we show how to consistently estimate each estimand via stratification. Furthermore, we describe when these estimands correspond to the same VE parameter and, when appropriate, propose a stratified estimator that can incorporate multiple reasons for testing and improve precision. We demonstrate the performance of our proposed method through simulation studies and a real-data analysis.</p>","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"228-236"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is Your Ideal Trial? 你理想的审判是什么?
IF 4.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2026-03-01 Epub Date: 2025-11-20 DOI: 10.1097/EDE.0000000000001934
Jeremy A Labrecque, Chang Wei, Richard A J Post
{"title":"What is Your Ideal Trial?","authors":"Jeremy A Labrecque, Chang Wei, Richard A J Post","doi":"10.1097/EDE.0000000000001934","DOIUrl":"10.1097/EDE.0000000000001934","url":null,"abstract":"","PeriodicalId":11779,"journal":{"name":"Epidemiology","volume":" ","pages":"163-165"},"PeriodicalIF":4.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145905928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1